logo

Hot Stocks

Share SHARE

Spectrum Pharmaceuticals Inc. (SPPI) announced Tuesday that the interim data from its Phase 2 clinical study of poziotinib in EGFR Exon 20 Mutant Non-Small-Cell Lung Cancer was presented in Yokohama, Japan. "All 11 study patients who received poziotinib at a 16mg daily dose and have reached their...

IBM Corp. (IBM) reported third quarter EPS of $3.30 after the bell Tuesday, compared to $3.29 in the prior year period. Street expectations were for EPS of $3.28. IBM has gapped open sharply higher Wednesday morning and is now up 11.42 at $157.96 on above average volume. The stock has surged to over a 5-month high.

Unitedhealth Group Inc. (UNH) reported third quarter EPS of $2.66 Tuesday morning, up from $2.17 last year. The consensus estimate was for EPS of $2.56. The company expects full year adjusted EPS to approach $10.00. Prior guidance had been for $9.75 to $9.90. Unitedhealth gapped up at the open...

Exelixis Inc. (EXEL) announced Monday morning that its Phase 3 trial of cabozantinib in patients with advanced hepatocellular carcinoma met its primary endpoint. The FDA has also granted priority review to cabozantinib for patients with previously untreated advanced renal cell carcinoma. Exelixis...

AnaptysBio Inc. (ANAB) reported positive results from its Phase 2a trial of ANB020 Tuesday morning. An Eczema Area Severity Index score improvement of 50 percent relative to enrollment baseline was observed in 75 percent of patients after a single dose. AnaptysBio has gapped open dramatically higher...

Follow RTT